Water Island Capital’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-168,385
Closed -$12.1M 131
2025
Q4
$12.1M Buy
+168,385
New +$10.9M 1.31% 29

Other funds holding RNAM

Water Island Capital's RNAM Position: Q1 2026 in Review

Water Island Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 168,385 shares — an estimated $12.1M sold.

Water Island Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Water Island Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Water Island Capital sold 168,385 Avidity Biosciences shares in Q1 2026, an estimated $12.1M.
  • Water Island Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Water Island Capital's Avidity Biosciences position peaked at $12.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Water Island Capital's 13F filing for Q1 2026, filed 15 May 2026.